Tianjin Medical University Second Hospital — Tianjin, Tianjin Municipality

Public research footprint of Tianjin Medical University Second Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Her2 Overexpressing High-Risk Non-Muscle Invasive Bladder Urothelial… · High-risk Non-muscle Invasive Bladder Cancer · Solid Tumor · Renal Cell Carcinoma (Kidney Cancer)

Recently updated registry entries

NCT07697417 — Multimodal Prediction of Postoperative Prognosis After Partial Nephrectomy for Endophytic… (Active Not Recruiting)
NCT07321210 — Radical Nephroureterectomy With vs Without Template Lymph Node Dissection in High-Risk… (Recruiting)
NCT07321197 — Radical Nephrectomy With vs Without Template Lymph Node Dissection in High-Risk Renal… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Tianjin Medical University Second Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.